Golden House (GOHO) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Golden House ILS 7.96, price ILS 10.17, upside -21.7%, quality 64 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Golden House for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range 7.70 ILA – 28.22 ILA · fair‑value band 6.68 ILA – 10.12 ILA · the 10.17 ILA price screens above the 7.96 ILA fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow Golden House in your weekly email
Every Wednesday you see whether Golden House is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Golden House Ltd engages in the operation and management of sheltered housing centers for the elderly population in Israel. It operates The Golden Age House, that contains housing units, as well as public areas, a lobby, a clubhouse, a library, cinema hall, computer room, synagogue, classrooms, lecture rooms, gym, and green garden terrace.
Show more
Golden House Ltd engages in the operation and management of sheltered housing centers for the elderly population in Israel. It operates The Golden Age House, that contains housing units, as well as public areas, a lobby, a clubhouse, a library, cinema hall, computer room, synagogue, classrooms, lecture rooms, gym, and green garden terrace. The company also offers nursing care services. In addition, it is involved in the renting of commercial buildings. The company was incorporated in 1982 and is headquartered in Tel Aviv-Yafo, Israel.
Stock analysis
Golden House (GOHO) currently trades at 10.17 ILA, while our model-based Fair Value estimate is 7.96 ILA, implying the stock looks roughly 27.8% overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 11.69 ILA per share, and 16 of the 24 models we run sit above the 10.17 ILA price.
Bear case: the Earnings-Based group reads lowest at 5.58 ILA, and 8 of the 24 models stay below the price. Evidence for this calculation is medium.
Scenario range: 6.68 ILA (bear) to 10.12 ILA (bull), the price of 10.17 ILA sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Golden House reported revenue of 48.9M ILS in FY2025 versus 56.2M ILS in FY2021, a compound −3.4%/yr. Reported net income was 7.3M ILS in FY2025, compounding −11.3%/yr from FY2021.
Key figures
Market cap 158M ILA · P/E ratio 23.1 · P/S ratio 3.44 · EPS (TTM) 0.4400 ILA · Dividend yield 1.2% · Net margin 14.9% · Return on equity −2.1% · Return on assets (EBIT) 4.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −22%, GOHO screens richer than that median.
Fair Value models
Bear 6.68 ILAFair Value 7.96 ILABull 10.12 ILA
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+22.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.0%
Start year 2020 (pandemic). Over 10 years: −1.1% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
−19.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−21.1%
Dividend (yield on the price)1.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−20% vs −6%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.35% → 13%
Start year 2020 (pandemic)
⚠ Revenue per share shrinking 2.3%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+9.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Israel: IMF forecast 2.1% a year to 2030, 1.7% from 2016 to 2025) that is about +7.2% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 258 stocks
Beats the industry median on 5/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score64 · Top 25%
Fair Value upside−22% · Below median
Profitability
Return on assets0% · Bottom 25%
Net margin (TTM)−14% · Bottom 25%
Operating margin (TTM)23% · Top 25%
Growth and dividend
Revenue growth18% · Top 25%
Dividend yield (TTM)1.2% · Below median
Balance sheet
Debt / equity0.05× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Golden House Fair Value". https://www.fairvalue-calculator.com/stock/GOHO
Frequently asked questions
Is Golden House (GOHO) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 7.96 ILA versus a price of 10.17 ILA, about −22% upside (overvalued).
What is the fair value of GOHO?
Our model-based fair value for Golden House is 7.96 ILA (as of Sep 23, 2026), built from audited fundamentals. The current price: 10.17 ILA.
What is the quality score of GOHO?
Golden House has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Golden House (GOHO)?
Our model-based price target is the fair value of 7.96 ILA (as of Sep 23, 2026) from 24 valuation models. Cautious scenario 6.68 ILA, optimistic scenario 10.12 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Golden House stock forecast for 2026?
Our models put fair value at 7.96 ILA, about −22% upside versus a price of 10.17 ILA (overvalued). Cautious scenario 6.68 ILA, optimistic scenario 10.12 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of Golden House (GOHO)?
Golden House reported trailing-twelve-month revenue of about 46.0M ILS (latest available figure, as of Sep 23, 2026).
Does Golden House pay a dividend?
Golden House currently shows a dividend yield of about 1.17% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Golden House (GOHO)?
For today's price to be fair in a discounted-cash-flow model, Golden House would have to grow free cash flow by +9.4 % per year for five years (discount rate 14.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -4.0 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of GOHO use?
Our models discount Golden House at 14.6 %: a base by market capitalisation (micro), country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Golden House that is +9.4 % per year a year over ten years, using the same discount rate (14.6 %) and the same formula as our fair value.
How much growth has Golden House (GOHO) delivered so far?
Over the past 5 years revenue at Golden House grew -4.0 % a year. The price currently implies +9.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Golden House (GOHO) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Golden House (+9.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Golden House (GOHO)?
The free-cash-flow yield on the price is 6.61 %: that much free cash flow Golden House produces per unit of market value. When it exceeds the discount rate of our models (14.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Golden House (GOHO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Golden House it is 7.96 ILA per share (as of Sep 23, 2026), against a price of 10.17 ILA. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Golden House stock overvalued or undervalued in 2026?
As of Sep 23, 2026, GOHO trades above its calculated fair value: price 10.17 ILA, fair value 7.96 ILA, a gap of about −22% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GOHO?
No. The price is what the market pays today (10.17 ILA); the fair value is what the company's own numbers justify (7.96 ILA). For Golden House the two are 2.21 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Golden House worth?
The market values Golden House at about 158M ILA (market capitalisation, as of Sep 23, 2026). Per share that is 10.17 ILA; our models calculate a fair value of 7.96 ILA per share.
What do the bullish and bearish scenarios say about GOHO?
Our models span a range for Golden House: cautious scenario 6.68 ILA, base 7.96 ILA, optimistic 10.12 ILA per share (as of Sep 23, 2026, price 10.17 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of GOHO?
Golden House trades at a price-to-earnings ratio of 23.1 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 7.96 ILA is built from several models across several years. Other multiples: P/B 0.2, P/S 1.1.
How solid is the balance sheet of Golden House (GOHO)?
Balance-sheet figures for Golden House (as of Sep 23, 2026): return on equity −2.1%, debt of 0.05 per unit of equity. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is GOHO from its 52-week high?
Golden House trades at 10.17 ILA, about 15% below its 52-week high of 11.94 ILA and 3% above the low of 9.86 ILA (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 7.96 ILA is for.
Which stocks are comparable to Golden House?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Golden House stock attractive at the current price?
The data as of Sep 23, 2026: price 10.17 ILA, calculated fair value 7.96 ILA (−22%), Quality Score 64/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GOHO calculated?
We run Golden House through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 7.96 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Golden House itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Golden House (GOHO)?
The closing price on Sep 24, 2026 was 10.17 ILA. Our model-based fair value is 7.96 ILA, about −22% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Golden House right now?
Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder. The price sits above our optimistic bull case: the favourable scenario is already priced in. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Where does the earnings growth of Golden House (GOHO) come from?
Earnings per share at Golden House grew +14.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share −2.1 %, EBIT margin −10.0 %, tax rate −0.4 %, residual (interest, one-offs) +29.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Golden House
How large is the market capitalisation of Golden House (GOHO)?
The market capitalisation of Golden House is 158M ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Golden House (GOHO)?
The price-to-sales ratio of Golden House is 3.44 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Golden House (GOHO)?
Earnings per share at Golden House are 0.4400 ILA (price ÷ EPS = P/E 23.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Golden House (GOHO)?
The dividend yield of Golden House is 1.2% (payout 27.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Golden House (GOHO)?
The net margin of Golden House is 14.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Golden House (GOHO)?
The return on equity (ROE) of Golden House is −2.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Golden House (GOHO)?
On an EBIT basis the return on assets of Golden House is 4.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Golden House (GOHO)?
The operating margin of Golden House is 22.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Golden House (GOHO)?
Revenue at Golden House is growing +18.2% versus a year earlier (3y avg −7.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Golden House (GOHO)?
Earnings per share at Golden House are growing −17.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Golden House (GOHO) hold?
Golden House holds more cash than debt, 18.1M ILA net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Golden House in the live analysis
One click puts Golden House on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
